.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
McKesson
Mallinckrodt
Teva
Farmers Insurance
Johnson and Johnson
Fish and Richardson
Cerilliant
Deloitte
Cantor Fitzgerald

Generated: September 22, 2017

DrugPatentWatch Database Preview

FROVA Drug Profile

« Back to Dashboard

Which patents cover Frova, and what generic Frova alternatives are available?

Frova is a drug marketed by Endo Pharms, Glenmark Pharms Ltd, and Mylan Pharms Inc. and is included in three NDAs.

The generic ingredient in FROVA is frovatriptan succinate. There are three drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the frovatriptan succinate profile page.

Summary for Tradename: FROVA

Patents:0
Applicants:3
NDAs:3
Suppliers / Packagers: see list5
Bulk Api Vendors: see list16
Clinical Trials: see list3
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:FROVA at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Endo Pharms
FROVA
frovatriptan succinate
TABLET;ORAL021006-001Nov 8, 2001ABRXYesYes► Subscribe► Subscribe► Subscribe
Glenmark Pharms Ltd
FROVATRIPTAN SUCCINATE
frovatriptan succinate
TABLET;ORAL204730-001Mar 11, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
FROVATRIPTAN SUCCINATE
frovatriptan succinate
TABLET;ORAL202931-001Aug 28, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: FROVA

Paragraph IV activity for: FROVA

Drugname Dosage Strength RLD Submissiondate
frovatriptan succinateTablets2.5 mgFrova3/9/2011
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Boehringer Ingelheim
Johnson and Johnson
Daiichi Sankyo
Fuji
McKesson
Teva
Express Scripts
Baxter
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot